.png){kind=logo}
Stock image for illustration purposes only - book cover, edition or condition may vary.
Optimizing the "Drug-Like" Properties of Leads in Drug Discovery
. Ed(S): Borchardt, Ronald T.; Kerns, Edward H.; Hageman, Michael J.; Thakker, Dhrien R.; Stevens, James L.
€ 254.05
FREE Delivery in Ireland
Description for Optimizing the "Drug-Like" Properties of Leads in Drug Discovery
Hardback. Based on the workshop, entitled "Pharmaceutical Profiling in Drug Discovery for Lead Selection", which took place in Whippany, on May 19-21, 2003. The workshop was focused on prediction, measurement, and utilization of drug-like properties during lead selection. Editor(s): Borchardt, Ronald T.; Kerns, Edward H.; Hageman, Michael J.; Thakker, Dhrien R.; Stevens, James L. Series: Biotechnology: Pharmaceutical Aspects. Num Pages: 522 pages, biography. BIC Classification: MMG. Category: (P) Professional & Vocational. Dimension: 254 x 178 x 28. Weight in Grams: 1123.
Drug discovery and development is a very complex, costly, and ti- consuming process. Because of the uncertainties associated with predicting the pharmacological effects and the toxicity characteristics of new chemical entities in man, their clinical development is quite prone to failure. In recent years, phar- ceutical companies have come under increasing pressure to introduce new blockbuster drugs into the marketplace more rapidly. Companies have responded to these pressures by introducing new technologies and new strategies to expedite drug discovery and development. Drug discovery and development have traditionally been divided into three separate processes (i. e. , discovery research, preclinical development, ... Read more
Drug discovery and development is a very complex, costly, and ti- consuming process. Because of the uncertainties associated with predicting the pharmacological effects and the toxicity characteristics of new chemical entities in man, their clinical development is quite prone to failure. In recent years, phar- ceutical companies have come under increasing pressure to introduce new blockbuster drugs into the marketplace more rapidly. Companies have responded to these pressures by introducing new technologies and new strategies to expedite drug discovery and development. Drug discovery and development have traditionally been divided into three separate processes (i. e. , discovery research, preclinical development, ... Read more
Product Details
Format
Hardback
Publication date
2006
Publisher
Springer-Verlag New York Inc. United States
Number of pages
522
Condition
New
Series
Biotechnology: Pharmaceutical Aspects
Number of Pages
512
Place of Publication
New York, NY, United States
ISBN
9780387340562
SKU
V9780387340562
Shipping Time
Usually ships in 15 to 20 working days
Ref
99-15
Reviews for Optimizing the "Drug-Like" Properties of Leads in Drug Discovery